Shares of iCo Therapeutics Inc (CVE:ICO) traded down 5.3% during trading on Thursday . The stock traded as low as C$0.09 and last traded at C$0.09. 250,537 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 692,418 shares. The stock had previously closed at C$0.10.
The company has a market cap of $10.65 million and a P/E ratio of -4.50.
TRADEMARK VIOLATION WARNING: “iCo Therapeutics (ICO) Shares Down 5.3%” was originally posted by Enterprise Leader and is the sole property of of Enterprise Leader. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this report can be accessed at https://theenterpriseleader.com/2019/03/16/ico-therapeutics-ico-shares-down-5-3.html.
iCo Therapeutics Company Profile (CVE:ICO)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Featured Article: Understanding Average Daily Trade Volume
Receive News & Ratings for iCo Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iCo Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.